ANI Pharmaceuticals (ANIP) Director Henry Gosebruch Receives Award

What Happened

• Henry O. Gosebruch, a director of ANI Pharmaceuticals, was granted 6,662 restricted shares on August 19, 2026. The grant was recorded as an acquisition (code A) at $0.00 per share (total reported value $0) — this is a restricted stock award, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-08-19; Filing date (SEC accession): 2026-08-27.
• Price: $0.00 per share; Shares acquired: 6,662; Reported total value at acquisition: $0.
• Shares owned after the transaction: Not specified in this filing.
• Footnote: The award vests in three equal annual installments on the first, second and third anniversaries of August 19, 2026.
• Filing timing: The Form 4 was filed 8 days after the transaction date (Aug 19 → Aug 27); the typical Form 4 deadline is 2 business days, so this filing appears later than the usual reporting window.

Context

• This was a compensation-related restricted stock grant to a director. Such awards are common for executive/director compensation and do not involve an immediate cash outlay or open-market trading. The vesting schedule means the shares will convert to unrestricted stock over the next three years if the vesting conditions are met.